Since PTPs affect FLT3 oncogenic signalling, modulation of PTP activity, such as inhibition of proto-oncogenic PTPs or enhancing the activity of tumour-suppressive PTPs, can directly influence the phosphorylation and activity of FLT3 proteins. The gene discussed is PTS; the disease is neoplasm.